1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Stada Grabs GSK Brands In Key EU Markets

 
• By Tom Gallen

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.

Europe
• Source: Shutterstock

Stada Arzneimittel AG is poised to enhance its consumer healthcare portfolio in both developed and developing European markets by acquiring from GlaxoSmithKline PLC a basket of 15 brands, mainly in the cold & flu, pain and skin-care categories. The transaction is expected to close in the second quarter of 2020.

While the value of the deal has not been disclosed, a spokesperson for Stada told HBW Insight that combined annual sales of the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Herbalife Expects No ‘Material’ Impact From China Tariff, Recent Deals To Bring ‘New Era’ Of Growth

 
• By Malcolm Spicer

Herbalife expects little impact from increased tariffs on imports from China but strong boosts from acquiring Pro2col Health and Pruvit Ventures Inc. and 51% ownership of Link BioSciences.

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By Tom Gallen

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.

Nestlé Health Science’s US VMS Recovery Stutters

 
• By Tom Gallen

US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.